- Nanobiotix will give two immuno-oncology presentations at the Society for Immunotherapy of Cancer (SITC) conference this month- Tolerability, safety and first tumor response data in liver cancer will be presented at the ASCO GI conference in January 2018- IND application in process of being filed in the U.S. for a combination trial with...